Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|June 27, 2023
An update on drug-drug interactions for care of the acutely ill in the era of COVID-19Asad E Patanwala, Nynke G L Jager, John J Radosevich, et al.
Therapeutic Drug Monitoring|May 14, 2014
Poor performance of laboratories assaying newly developed antiretroviral agents: results for darunavir, etravirine, and raltegravir from the international quality control program for therapeutic drug monitoring of antiretroviral drugs in human plasma/serumDavid Burger, Stefanie Krens, Karen Robijns, et al.
Clinical Trials (London, England)|May 5, 2022
Risk-proportionate approach to paediatric clinical trials: The legal requirements, challenges, and the way forward under the European Union Clinical Trials RegulationMandy Wan, Elisa Alessandrini, Paul Brogan, et al.
Medical Mycology Case Reports|March 14, 2014
Screening of the central nervous system in children with invasive pulmonary aspergillosisEmmi Broenen, Annelies Mavinkurve-Groothuis, Karin Kamphuis-van Ulzen, et al.
Medical Mycology|July 12, 2019
Antifungal drugs: What brings the future?Ruth Van Daele, Isabel Spriet, Joost Wauters, et al.
International Journal of Clinical Pharmacy|November 2, 2021
Variation in vancomycin dosing and therapeutic drug monitoring practices in neonatal intensive care unitsAnouk van der Veen, Annemie Somers, Sophie Vanhaesebrouck, et al.
Medical Mycology|October 10, 2017
Amphotericin B and terbinafine but not the azoles prolong survival in Galleria mellonella larvae infected with Madurella mycetomatisWendy Kloezen, Florianne Parel, Roger Brüggemann, et al.
Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology|April 7, 2017
Ultra-small superparamagnetic iron oxides for metastatic lymph node detection: back on the blockAnsje S Fortuin, Roger Brüggemann, Janine van der Linden, et al.
Antimicrobial Agents and Chemotherapy|April 20, 2026
Evaluation of the cytochrome P450-mediated drug interaction profile of olorofimKaren Cornelissen, John H Rex, Daniela Zinzi, et al.
British Journal of Clinical Pharmacology|May 17, 2020
Prospective validation of a model-informed precision dosing tool for vancomycin in intensive care patientsRob Ter Heine, Ron J Keizer, Krista van Steeg, et al.
Pageof 2